Chemomab Therapeutics (CMMB) Live Share Price, Invest From India

Chemomab Therapeutics Stock Performance

as on October 3, 2026 at 2:16 pm IST

Day's Low
Day's High
$1.32
Day's Price Range
$1.44
$1.43
7.69%
Downside
0.70%
Upside
52 Week's Low
52 Week's High
$1.05
52-Week Price Range
$3.58
$1.43
26.50%
Downside
150.35%
Upside

Chemomab Therapeutics share price movements today

Previous Close: $1.30
Open: $1.34
Volume: 361.6K
Market Cap: $9.5M
Day's Low - High: $1.32 - $1.44
52 Week Low - High: $1.05 - $3.58

Chemomab Therapeutics Historical Returns

1 Month Return: -49.47 %
3 Month Return: -37 %
1 Year Return: -47.43 %
3 Year Return: -60.28 %
5 Year Return: -96.69 %

Chemomab Therapeutics Stock Fundamentals & Key Indicators

Check Chemomab Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$9.5M

EPS (TTM)

-1.02

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.29

Industry PE ratio

-3.02

PEG Ratio

-0.01

EBITDA

-7.9M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-70.81%

Chemomab Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Chemomab Therapeutics with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Chemomab Therapeutics	Buy	$9.5M	-96.69%	-1.29	0.00%	0.00%
Revolution Medicines	StrongBuy	$44.1B	609.62%	-23.34	0.00%	0.00%
Moderna	Neutral	$75.4B	-44.29%	-24.08	-12.57%	0.00%
Vertex Pharmaceuticals	StrongBuy	$132.5B	180.98%	30.19	86.04%	0.00%
Regeneron	Buy	$78.1B	28.80%	17.67	84.86%	0.50%

Stock Returns calculator for Chemomab Therapeutics Stock including INR - Dollar returns

The Chemomab Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Chemomab Therapeutics investment value today

Current value as on today

₹57,065

Returns

-₹42,935

(-42.94%)

Returns from Chemomab Therapeutics Stock

-₹47,426 (-47.43%)

Dollar Impact

₹4,491 (+4.49%)

Analyst Recommendation on Chemomab Therapeutics Stock

Based on 8 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

Based on 8 analysts, 75% of analysts recommend a 'BUY' rating for Chemomab Therapeutics. Average target price of $5

Chemomab Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Chemomab Therapeutics.

What analysts predicted

71.4%UPSIDE

Target Price

Current Price

$1.43

Analyzed by

8 Analysts

Target

$5.00

Chemomab Therapeutics target price $5, a slight upside of 71.4% compared to current price of $1.43. According to 8 analysts rating.

Indian Investors' Interest in Chemomab Therapeutics Stock

Search interest for Chemomab Therapeutics Stock has decreased by -10% in the last 30 days, reflecting a downward trend in search activity.

Time period: September 5, 2026 to October 5, 2026

Change:-10% versus previous 30 day period

Chemomab Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	0	-	-	-	-	-	-	-	-
Operating Income	-4	-3	-3	-3	-3	-2	-1	-1	-1	-2
EBITDA	-4	-3	-3	-3	-3	-2	-1	-1	-1	-2
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	0	0	0	0	0	0	0	0	-
Income Before Tax	-3	-3	-3	-2	-3	-2	-1	-1	-1	-2
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-3	-3	-3	-2	-3	-2	-1	-1	-1	-2
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Chemomab Therapeutics Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Mar 2023	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	-	-
Operating Income	-9	-13	-19	-11	-12	-28	-25	-14	-9
EBITDA	-9	-13	-26	-10	-12	-28	-25	-14	-9
Interest Expense	0	-	0	-	0	0	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0
Income Before Tax	-9	-5	-27	-11	-12	-28	-24	-13	-8
Income Tax Expense	0	0	-	-	-	0	-	-	-
Net Income	-9	-13	-27	-11	-12	-27	-24	-13	-8
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Chemomab Therapeutics Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-3	-3	-3	-2	-3	-2	-1	-1	-1	-2
Operating Cash Flow	-	-	-	-	-	-	-	-11	-	-
Investing Cash Flow	-	-	-	-	-	-	-	5	-	-
Financing Cash Flow	-	-	-	-	-	-	-	7	-	-
Change in Cash	-4	0	1	0	2	-2	1	0	-	-

Chemomab Therapeutics Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Mar 2023	Dec 2023	Dec 2024	Dec 2025
Net Income	-9	-13	-27	-11	-12	-27	-24	-14	-9
Operating Cash Flow	-8	-14	-16	-12	-12	-20	-23	-15	-11
Investing Cash Flow	0	0	0	0	-45	19	15	2	5
Financing Cash Flow	5	20	26	0	61	0	3	9	7
Change in Cash	-3	6	10	-12	55	-47	-4	-3	1

Global Institutional Holdings in Chemomab Therapeutics

Check out the Institutions with significant holdings in Chemomab Therapeutics.

Funds	Holdings
Advisory Services Network, LLC	0.00%

Insights on Chemomab Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 566.9% return, outperforming this stock by 614.3%
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 82.2% return, outperforming this stock by 140.9%
NEGATIVE IMPACT
Price Dip
In the last 7 days, CMMB stock has moved down by -33.8%

About Chemomab Therapeutics

Chemomab Therapeutics Ltd. operates as a clinical-stage biotechnology firm, dedicated to identifying and advancing novel treatments for inflammatory and fibrotic conditions. Its leading experimental drug candidate, CM-101, is a humanized monoclonal antibody specifically engineered to impede the core function of soluble chemokine CCL24. This potential therapy is currently under investigation for its efficacy in managing primary sclerosing cholangitis (PSC) and systemic sclerosis (SSc). Established in 2011, the company, formerly known as Anchiano Therapeutics Ltd., adopted its current name, Chemomab Therapeutics Ltd., in March 2021 and is headquartered in Tel Aviv, Israel.

Organisation	Chemomab Therapeutics
Headquarters	Building C, Tel Aviv-Yafo, TA, 6158101, IL
Industry	Biotechnology
CEO	Adi Mor George

Key Management of Chemomab Therapeutics

Name	Title
Dr. Adi Mor George Ph.D.	Co-Founder, Chief Scientific Officer, CEO & Executive Director
Ms. Sigal Fattal CPA, M.B.A.	Chief Financial Officer
Mr. John Lawler	Chief Development Officer
Ms. Barbara L. Lindheim	Consulting Vice President of Investor & Public Relations, Strategic Communications
Dr. David M. Weiner M.B.A., M.D.	Interim Chief Medical Officer

FAQs

What is Chemomab Therapeutics share price today?

Chemomab Therapeutics share price today is $1.43 as on October 3, 2026 at 8:46 am IST at the close of the market. Chemomab Therapeutics share today touched a day high of $1.44 and a low of $1.32.

What is the 52 week high and 52 week low for Chemomab Therapeutics share?

Chemomab Therapeutics share touched a 52 week high of $3.58 on October 7, 2025 and a 52 week low of $1.05 on September 30, 2026. Chemomab Therapeutics stock price today i.e. October 3, 2026 at 8:46 am IST is closed at $1.43,which is 60.06% down from its 52 week high and 36.06% up from its 52 week low.

What is Chemomab Therapeutics's market capitalisation today?

Chemomab Therapeutics market capitalisation is $0.00T as on October 3, 2026 at 8:46 am IST.

How to invest in Chemomab Therapeutics Stock (CMMB) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Chemomab Therapeutics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Chemomab Therapeutics Stock (CMMB) from India?

Indian investors can start investing in Chemomab Therapeutics (CMMB) shares with as little as ₹96.300003051758 or $1 (as of October 5, 2026 at 5:45 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹963.00 in Chemomab Therapeutics stock (as per the Rupee-Dollar exchange rate as on October 5, 2026 at 5:45 am IST). Based on Chemomab Therapeutics share’s latest price of $1.43 as on October 3, 2026 at 8:46 am IST, you will get 6.9930 shares of Chemomab Therapeutics. Learn more about fractional shares .

What are the returns that Chemomab Therapeutics has given to Indian investors in the last 5 years?

Chemomab Therapeutics stock has given -96.69% share price returns and 29.14% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?